Laura Haney

Laura Haney is a seasoned professional with extensive experience in IT business analysis and financial systems support. Currently serving as a Senior Principal Analyst in Business Engagement & Technology at Vertex Pharmaceuticals since March 2022, Laura has previously held key positions at Karyopharm Therapeutics Inc. and Eliassen/Boston Consulting Group. Notable accomplishments include overseeing data migration projects, establishing risk management practices at John Hancock, and contributing to the development of financial systems at AW Chesterton. Laura holds an MBA in Accounting from Clark University and a B.S. in Finance from Northeastern University.